CMC Consultant @ ProBio Development Partners (April 2024 - Present)
Technical Fellow and Vice President, Research and Development @ (January 2018 - April 2024)
Research Advisor, Drug Product development @ Eli Lilly and Company (January 2016 - January 2017)
Director, Formulation development @ Eli Lilly and Company (January 2009 - January 2016)
Associate Director, Formulation development @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (January 2007 - January 2009)
Senior Manager, Formulation development @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (January 2006 - January 2007)
Senior Scientist, Formulation development @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (January 2005 - January 2006)
Scientist, Formulation development @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (January 2003 - January 2005)
Arvind Srivastava Education
The University of North Carolina at Chapel Hill
Postdoc (Biochemistry)
Banaras Hindu University
Master of Science - MS (Chemistry)
Tata Institute of Fundamental Research, Mumbai
Doctor of Philosophy - PhD (Chemistry)
Arvind Srivastava Summary
Arvind Srivastava, based in New York, NY, US, is currently a Senior Vice President, CMC at Third Arc Bio. Arvind Srivastava brings experience from previous roles at ProBio Development Partners, Avantor and Eli Lilly and Company. Arvind Srivastava holds a Postdoc in Biochemistry @ The University of North Carolina at Chapel Hill. Arvind Srivastava has 1 emails and 3 mobile phone numbers on RocketReach.
Looking for a different Arvind Srivastava?
Find contact details for 700 million professionals.